openPR Logo
Press release

Transcatheter aortic valve replacement (TAVR) Market Current Business Trends & Growth Opportunities Over 2029

06-24-2022 08:45 AM CET | Health & Medicine

Press release from: Exactitude Consultancy

Demand Analysis of Transcatheter Aortic Valve Replacement (TAVR) Market Overview:

The Transcatheter aortic valve replacement (TAVR) Market is predicted to grow at a moderate CAGR of 22% during the forecast period covering 2022 to 2029. Transcatheter aortic valve replacement (TAVR) Market share is estimated to reach a value of nearly US$ 26 billion by 2029.

The "Transcatheter Aortic Valve Replacement (TAVR) Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the market. An in-depth examination of the by and large development prospects for the worldwide and regional market was given which was based on an in-depth investigation of key industry players, essential and secondary information.

Request to Download Free Sample of Transcatheter Aortic Valve Replacement (TAVR) Market Report:
https://exactitudeconsultancy.com/reports/3811/transcatheter-aortic-valve-replacement-tavr-market/#request-a-sample?mode=akshay

Transfemoral implantation segment holds the highest share of the transcatheter aortic valve replacement (TAVR) market in owing to advanced technology including vascular closure systems. Transfemoral implantation is a minimally invasive which helps to recover fast as well as it decreases the overall length of hospital stay. This factor is expected to fuel the growth of transfemoral implantation segment during the forecast period.

The standardized TAVI approach, in which an artificial valve is inserted through the femoral artery with little anesthetic, is known as transfemoral implantation. However, there are some patients who are unable to have transfemoral TAVI because their arteries are weak and tiny. Transapical implantation, in which the artificial valve is implanted through the left ventricular apex, is favored in this circumstance. Transaortic implantation is also designed for individuals with weak femoral arteries and poor respiratory function, making them ineligible for both transfemoral and transapical TAVI procedures.

Industry Developments-

In 2019, Medtronic has released Evolut PRO+. It is a transcatheter aortic valve replacement (TAVR) system.

In 2019, Meril Life Sciences has introduced TAVR technology namely MyvalTM -THV system. This company became the first Indian company to market and distribute its indigenously designed and patented TAVR technology, MyvalTM -THV system, to the European Union and other countries.

Competitive and Segmentation Analysis-
As well as giving an outline of effective promoting procedures, market contributions, and later improvements of driving companies, the report moreover offers a dashboard diagram of driving companies' past and display execution. A few strategies and analyses are utilized within the inquire about report to supply in-depth and precise data approximately the Transcatheter Aortic Valve Replacement (TAVR) Market.

Market Growth Reports lists out all the Global companies that are presently striving to reduce the impact of Covid-19 pandemic on the market:, CryoLife, Inc., Abbott; Micro Interventional Devices, Inc., Boston Scientific Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., Edwards Lifesciences Corporation, Medtronic, Auto Tissue Berlin GmbH, lepumedical.com, Neovasc Inc., TTK HealthCare and JenaValve Technology, Inc, and others.

Report provides comprehensive information about the strategies of the top companies in the industry, along with a broad study of the different market segments and regions.

Key Segments
Global Transcatheter Aortic Valve Replacement (TAVR) Market by Procedure, 2020-2029, (USD Million)

Transfemoral Implantation
Transapical Implantation
Transaortic Implantation

Global Transcatheter Aortic Valve Replacement (TAVR) Market by End User, 2020-2029, (USD Million)

Hospitals
Ambulatory Surgical Centers
Others

Detailed Table of Content

Introduction
Research Scope
Market Segmentation
Research Methodology and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Global Market Overview
Key Market Indicators
Emerging Market Trends
Macro and Micro Economic Factors
Production Process Analysis
Industry SWOT Analysis

Browse Complete Premium Research Report link-
https://exactitudeconsultancy.com/reports/3811/transcatheter-aortic-valve-replacement-tavr-market/

Global Transcatheter Aortic Valve Replacement (TAVR) Market, by Region

North America is estimated to grasp a high growth rate due to the growing R&D investments for product development and innovation of healthcare sector. The markets in Italy and the United Kingdom may see huge increases in this region. Growing healthcare spending, bolstered by research and development into the use of transcatheter aortic valve replacement (TVAR) in medical sector, may favor product demand. The presence of key businesses engaged in product innovation for a broad range of applications will help the area sector grow.

North America (U.S., Canada, Mexico)
Europe (U.K., France, Germany, Spain, Italy, Central and Eastern Europe)
Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
Middle East and Africa (Turkey, GCC, Rest of Middle East)
Research Methodology-
Secondary research, primary research, subject matter expert assistance, quality check, and final review were the five phases of the research study on the Transcatheter Aortic Valve Replacement (TAVR) Market. Market statistics and coherent models were used to assess and forecast market data. Market shares and significant trends were also taken into account when preparing the research. Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis, and Vendor Share Analysis are some of the various data models available.

Highlights of Transcatheter Aortic Valve Replacement (TAVR) Market:

Market Expansion: Comprehensive information on the product portfolios of the top players in the Transcatheter Aortic Valve Replacement (TAVR) Market Size.

Product Development/Innovation: Detailed insights on the upcoming technologies, R and D activities, and product launches in the market

Evaluation of Competitors: depth assessment of the market strategies, geographic and business segments of the leading players in the market

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.

Diversification of the Market: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Transcatheter Aortic Valve Replacement (TAVR) Market.

Reasons to Purchase this Report

The most recent market developments, market shares, and strategies implemented by the major market players
The market segment that is expected to dominate, as well as the market segment with the highest CAGR throughout the forecast period
The current and future state of the global cryogenic equipment industry in developed and emerging markets
Regions/countries expected to have the fastest growth rates at some point during the forecast period

Connect us on:
You Tube Link- https://www.youtube.com/channel/UCts2fMbshxihDcnv2yRtvBg
Linked In- https://www.linkedin.com/company/exactitudeconsultancy/
Twitter- https://twitter.com/ExactitudeCons
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

About Us: Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transcatheter aortic valve replacement (TAVR) Market Current Business Trends & Growth Opportunities Over 2029 here

News-ID: 2661609 • Views:

More Releases from Exactitude Consultancy

Chemotherapy Induced Nausea and Vomiting Market Massive Growth opportunity Ahead
Chemotherapy Induced Nausea and Vomiting Market Massive Growth opportunity Ahead
Introduction Chemotherapy remains a cornerstone of cancer treatment, but it comes with a heavy burden of side effects. Among these, nausea and vomiting are among the most distressing, significantly impacting patient quality of life and adherence to therapy. Chemotherapy-induced nausea and vomiting (CINV) can lead to treatment discontinuation, malnutrition, and hospitalization if poorly managed, making effective supportive care a critical part of oncology practice. Over the past decade, advances in serotonin (5-HT3)
Cervix Lesion Market Outlook 2025-2034: Screening, Early Detection, and Advanced Therapies Driving Progress
Cervix Lesion Market Outlook 2025-2034: Screening, Early Detection, and Advanced …
In 2024, the global cervix lesion market is valued at USD 2.9 billion and is projected to reach USD 6.1 billion by 2034, growing at a CAGR of 7.8% (2025-2034). The steady rise reflects the combined effect of heightened awareness, government-led prevention programs, and innovative diagnostic and therapeutic approaches. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71190 Market Overview: Key Highlights Market Size (2024): USD 2.9 Billion Forecasted Market Size (2034): USD
c-MET Mutated Non-Small Cell Lung Cancer (NSCLC) Market Outlook 2025-2034: Precision Oncology Driving Growth
c-MET Mutated Non-Small Cell Lung Cancer (NSCLC) Market Outlook 2025-2034: Preci …
In 2024, the global c-MET mutated NSCLC market is valued at USD 1.2 billion and is projected to reach USD 3.5 billion by 2034, growing at a CAGR of 11.4% (2025-2034). This strong trajectory reflects rising adoption of molecular testing, broader access to MET inhibitors, and robust clinical trial activity across regions. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71188 Market Overview: Key Highlights Market Size (2024): USD 1.2 Billion Forecasted Market
Carcinoid Tumor Market Outlook 2025-2034: Expanding Diagnostics and Targeted Therapies Driving Growth
Carcinoid Tumor Market Outlook 2025-2034: Expanding Diagnostics and Targeted The …
In 2024, the global carcinoid tumor market is estimated at USD 2.4 billion and is projected to reach USD 5.1 billion by 2034, growing at a CAGR of 7.6% (2025-2034). Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71186 Market Overview: Key Highlights Market Size (2024): USD 2.4 Billion Forecasted Market Size (2034): USD 5.1 Billion CAGR (2025-2034): 7.6% Largest Region (2024): North America (~45% share) Fastest-Growing Region: Asia-Pacific (>9% CAGR) Top Therapies: Somatostatin analogs (octreotide, lanreotide),

All 5 Releases


More Releases for TAVR

TAVR Market Leads Heart Health Revolution with Surging Innovations
The global transcatheter aortic valve replacement (TAVR) market size is expected to be valued at USD 4.28 billion in 2024 and reach USD 10.02 billion by 2029, growing at a CAGR of 18.50 % from 2024 to 2029. Transcatheter aortic valve replacement is a procedure that replaces a diseased aortic valve with a transcatheter aortic valve, which regenerates the blood-pumping function of the heart aortic valve. Global TAVR Market Report Scope: • Market Size
Transcatheter Aortic Valve Replacement (TAVR) Market Status and Global Outlook 2 …
Global Transcatheter Aortic Valve Replacement (TAVR) Market Research Report:(US$ 900) This Report Provides an overview of the Transcatheter Aortic Valve Replacement (TAVR) market, containing global revenue, global production, sales, and CAGR. Also describe Transcatheter Aortic Valve Replacement (TAVR) product scope, market overview, market opportunities, market driving force, and market risks. The forecast and analysis of the Transcatheter Aortic Valve Replacement (TAVR) market by type, application, and region are also presented. The next part of the report provides
Transcatheter Aortic Valve Replacement (TAVR) Global Market 2019
Press Release – 30 Jan 2019 Research and Development News -- . . Latest Update "Global Transcatheter Aortic Valve Replacement (TAVR) Market (Value, Volume): Analysis By Type of Approach (Transfemoral, Transapical), By Region, By Country (2018 Edition): Forecast to 2023 - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, France, United Kingdom, India, Japan China, Brazil, South Africa)" with Industries Survey | Global Current Growth and Future. ' ' A
Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Factors reveale …
According to the report “Global Transcatheter Aortic Valve Replacement (TAVR) Market,” published by Market Data Forecast, the global market is projected to reach USD 4.29 billion by 2021, at a CAGR of 18.50% from 2016 to 2021. Transcatheter aortic valve replacement (TAVR) is described as minimally invasive procedure replaces the improper functioning aortic valves. TAVR offers an efficient valve replacement procedure as compared to open-heart surgery for the benefit of high
North America Transcatheter Aortic Valve Replacement (TAVR) Market Size, share a …
According to the report North America Transcatheter Aortic Valve Replacement (TAVR) Market, published by Market Data Forecast, the global market is projected to reach USD 1.34 billion by 2021, at a CAGR of 16.80% from 2016 to 2021. For full report refer to http://www.marketdataforecast.com/market-reports/north-america-transcatheter-aortic-valve-replacement-market-358/ Transcatheter aortic valve replacement (TAVR)is described as minimally invasive procedure replaces the improper functioning aortic valves. TAVR offers an efficient valve replacement procedure as compared to open-heart surgery
Global Transcatheter Aortic Valve Replacement (TAVR) Market Outlook to 2019
Transcatheter aortic valve replacement (TAVR) is a relatively new technology in the field of medical science. It is a less invasive method of replacing heart valve without undergoing the conventional by-pass surgery. Aortic valve replacement typically requires open heart surgery, thus it disqualifies patients who are at high risk for the process or are too weak to undergo a surgery. As a result, the market of heart valve surgical procedures